Generic Name and Formulations:
Bimatoprost 0.03%; oph soln; contains benzalkonium chloride.
Indications for LATISSE:
Hypotrichosis of the eyelashes.
1 drop once nightly; apply evenly along upper eyelid skin margin at the base of eyelashes. Repeat for opposite eyelid margin with new sterile applicator. Blot any excess solution runoff.
Do not apply to lower eyelash line. Repeated contact with bimatoprost outside the treatment area may cause hair growth. Ocular hypertension; monitor for changes to intraocular pressure. Ocular inflammation (eg, uveitis). Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Contact lenses (remove; may reinsert lenses 15 minutes after administration). Pregnancy (Cat.C). Nursing mothers.
Concomitant with other intraocular pressure (IOP)-lowering prostaglandin analogues may decrease IOP-lowering effects.
Eye pruritus, conjunctival hyperemia, increased ocular pigmentation (iris, eyelid; may be permanent), ocular irritation, dry eye, erythema of the eyelid, macular edema, abnormal hair growth.
Soln—3mL (w. disposable sterile applicators)
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Comorbid Narcolepsy and Schizophrenia in Adolescents
- Ketamine in Electroconvulsive Therapy Accelerates Antidepressive Effects
- Quetiapine Exposure Does Not Appear to Increase Risk for Infant Malformations
- Selective Serotonin Reuptake Inhibitors May Increase Risk for Suboptimal Fetal Growth
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Prenatal Insecticide Exposure in Mother May Be Linked to Risk for Autism in Children